{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:45:46Z","timestamp":1791585946270,"version":"4.3.4"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.dld.2024.12.004","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T20:42:02Z","timestamp":1734468122000},"page":"669-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR)"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-5655","authenticated-orcid":false,"given":"Eddy","family":"Cotte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine","family":"Arquilliere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Artru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Baptiste","family":"Bachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3948-4156","authenticated-orcid":false,"given":"Leonor","family":"Benhaim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Bibeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2125-0503","authenticated-orcid":false,"given":"Niki","family":"Christou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Conroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4646-4778","authenticated-orcid":false,"given":"J\u00e9rome","family":"Doyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hoeffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0148-4695","authenticated-orcid":false,"given":"Nicolas","family":"Meillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mirabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Pioche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonor","family":"Rivin Del Campo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Vendrely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dld.2024.12.004_bib0001","first-page":"767\u201173","article-title":"[Epidemiology of colorectal cancer]","volume":"65","author":"Bouvier","year":"2015","journal-title":"Rev Prat"},{"issue":"4","key":"10.1016\/j.dld.2024.12.004_bib0002","doi-asserted-by":"crossref","first-page":"359\u201167","DOI":"10.1016\/j.dld.2017.01.152","article-title":"Rectal cancer: French Intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"49","author":"G\u00e9rard","year":"2017","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2024.12.004_bib0003","article-title":"Th\u00e9saurus national de canc\u00e9rologie digestive","author":"Cotte","year":"2023","journal-title":"Cancer du rectum"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0004","doi-asserted-by":"crossref","first-page":"330\u201144","DOI":"10.1148\/radiol.13121361","article-title":"The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the \u00ab DISTANCE \u00bb?","volume":"268","author":"Nougaret","year":"2013","journal-title":"Radiology"},{"issue":"Suppl 6","key":"10.1016\/j.dld.2024.12.004_bib0005","doi-asserted-by":"crossref","first-page":"vi81","DOI":"10.1093\/annonc\/mdt240","article-title":"Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Glimelius","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.dld.2024.12.004_bib0006","series-title":"TNM Classification of Malignant Tumours","author":"Brierley","year":"2017"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0007","doi-asserted-by":"crossref","first-page":"256\u201163","DOI":"10.1200\/JCO.2009.23.9194","article-title":"Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes","volume":"28","author":"Gunderson","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.dld.2024.12.004_bib0008","doi-asserted-by":"crossref","first-page":"1638\u201144","DOI":"10.1200\/JCO.2009.25.8376","article-title":"Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12\/0405-Prodige 2","volume":"28","author":"G\u00e9rard","year":"2010","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.dld.2024.12.004_bib0009","doi-asserted-by":"crossref","first-page":"794\u20119","DOI":"10.1097\/SLA.0000000000000988","article-title":"R1 rectal resection: look up and don't look down","volume":"260","author":"Tilly","year":"2014","journal-title":"Ann Surg"},{"issue":"9666","key":"10.1016\/j.dld.2024.12.004_bib0010","doi-asserted-by":"crossref","first-page":"821\u20118","DOI":"10.1016\/S0140-6736(09)60485-2","article-title":"Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial","volume":"373","author":"Quirke","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0011","doi-asserted-by":"crossref","first-page":"19\u201123","DOI":"10.1007\/s003840050072","article-title":"Pathological features of rectal cancer after preoperative radiochemotherapy","volume":"12","author":"Dworak","year":"1997","journal-title":"Int J Colorectal Dis"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0012","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2559.2005.02176.x","article-title":"Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer","volume":"47","author":"Ryan","year":"2005","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0013","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0014","doi-asserted-by":"crossref","first-page":"367\u201187","DOI":"10.1148\/rg.2019180114","article-title":"MRI of rectal cancer: tumor staging, imaging techniques, and management","volume":"39","author":"Horvat","year":"2019","journal-title":"Radiographics"},{"issue":"4","key":"10.1016\/j.dld.2024.12.004_bib0015","doi-asserted-by":"crossref","first-page":"623\u20117","DOI":"10.1111\/j.1572-0241.2004.04116.x","article-title":"Assessment of clinical impact of endoscopic ultrasound on rectal cancer","volume":"99","author":"Harewood","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.dld.2024.12.004_bib0016","first-page":"270\u201197","article-title":"Colorectal polypectomy and endoscopic mucosal resection (EMR): European society of gastrointestinal endoscopy (ESGE) clinical guideline","volume":"49","author":"Ferlitsch","year":"2017","journal-title":"Endoscopy."},{"issue":"6","key":"10.1016\/j.dld.2024.12.004_bib0017","doi-asserted-by":"crossref","first-page":"591\u2011622","DOI":"10.1055\/a-1811-7025","article-title":"Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2022","volume":"54","author":"Pimentel-Nunes","year":"2022","journal-title":"Endoscopy."},{"issue":"5","key":"10.1016\/j.dld.2024.12.004_bib0018","doi-asserted-by":"crossref","first-page":"494\u2011501","DOI":"10.1016\/S1470-2045(08)70129-3","article-title":"Controversies of total mesorectal excision for rectal cancer in elderly patients","volume":"9","author":"Rutten","year":"2008","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0019","doi-asserted-by":"crossref","first-page":"246\u201152","DOI":"10.1016\/j.radonc.2015.04.003","article-title":"Clinical complete response (cCR) after neoadjuvant chemoradiotherapy and conservative treatment in rectal cancer. Findings from the ACCORD 12\/PRODIGE 2 randomized trial","volume":"115","author":"G\u00e9rard","year":"2015","journal-title":"Radiother Oncol"},{"issue":"10093","key":"10.1016\/j.dld.2024.12.004_bib0020","doi-asserted-by":"crossref","first-page":"469\u201179","DOI":"10.1016\/S0140-6736(17)31056-5","article-title":"Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial","volume":"390","author":"Rullier","year":"2017","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.dld.2024.12.004_bib0021","doi-asserted-by":"crossref","first-page":"465\u201174","DOI":"10.1016\/S2468-1253(19)30410-8","article-title":"Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial","volume":"5","author":"Rullier","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8496","key":"10.1016\/j.dld.2024.12.004_bib0022","first-page":"1479\u201182","article-title":"Recurrence and survival after total mesorectal excision for rectal cancer","volume":"1","author":"Heald","year":"1986","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0023","doi-asserted-by":"crossref","first-page":"80\u20115","DOI":"10.1245\/ASO.2003.04.010","article-title":"Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy","volume":"10","author":"Moore","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"14","key":"10.1016\/j.dld.2024.12.004_bib0024","doi-asserted-by":"crossref","first-page":"1324\u201132","DOI":"10.1056\/NEJMoa1414882","article-title":"A randomized trial of laparoscopic versus open surgery for rectal cancer","volume":"372","author":"Bonjer","year":"2015","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.dld.2024.12.004_bib0025","doi-asserted-by":"crossref","first-page":"1569\u201180","DOI":"10.1001\/jama.2017.7219","article-title":"Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: The ROLARR randomized clinical trial","volume":"318","author":"Jayne","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.dld.2024.12.004_bib0026","doi-asserted-by":"crossref","first-page":"638\u201146","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.dld.2024.12.004_bib0027","doi-asserted-by":"crossref","first-page":"1114\u201123","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N Engl J Med"},{"issue":"28","key":"10.1016\/j.dld.2024.12.004_bib0028","doi-asserted-by":"crossref","first-page":"4620\u20115","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.dld.2024.12.004_bib0029","doi-asserted-by":"crossref","first-page":"1926\u201133","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer","year":"2012","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.dld.2024.12.004_bib0030","doi-asserted-by":"crossref","first-page":"2773\u201180","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"Aschele","year":"2011","journal-title":"J Clin Oncol"},{"issue":"36","key":"10.1016\/j.dld.2024.12.004_bib0031","doi-asserted-by":"crossref","first-page":"4558\u201165","DOI":"10.1200\/JCO.2012.42.8771","article-title":"Clinical outcome of the ACCORD 12\/0405 PRODIGE 2 randomized trial in rectal cancer","volume":"30","author":"G\u00e9rard","year":"2012","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.dld.2024.12.004_bib0032","doi-asserted-by":"crossref","first-page":"djv248","DOI":"10.1093\/jnci\/djv248","article-title":"Neoadjuvant 5-FU or capecitabine plus radiation with or without oxaliplatin in rectal cancer patients: a phase III randomized clinical trial","volume":"107","author":"Allegra","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"31","key":"10.1016\/j.dld.2024.12.004_bib0033","doi-asserted-by":"crossref","first-page":"3827\u201133","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: trans-tasman radiation oncology group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.dld.2024.12.004_bib0034","doi-asserted-by":"crossref","first-page":"972\u20118","DOI":"10.1002\/bjs.9811","article-title":"Tumour regression in the randomized Stockholm III trial of radiotherapy regimens for rectal cancer","volume":"102","author":"Pettersson","year":"2015","journal-title":"Br J Surg"},{"issue":"31","key":"10.1016\/j.dld.2024.12.004_bib0035","doi-asserted-by":"crossref","first-page":"3773\u201180","DOI":"10.1200\/JCO.2016.67.6049","article-title":"Effect of interval (7 or 11 weeks) between neoadjuvant radiochemotherapy and surgery on complete pathologic response in rectal cancer: a multicenter, randomized, controlled trial (GRECCAR-6)","volume":"34","author":"Lefevre","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.dld.2024.12.004_bib0036","doi-asserted-by":"crossref","first-page":"747\u201154","DOI":"10.1097\/SLA.0000000000003530","article-title":"Does a longer waiting period after neoadjuvant radio-chemotherapy improve the oncological prognosis of rectal cancer?: Three years\u2019 follow-up results of the greccar-6 randomized multicenter trial","volume":"270","author":"Lef\u00e8vre","year":"2019","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.dld.2024.12.004_bib0037","doi-asserted-by":"crossref","first-page":"701\u20115","DOI":"10.1016\/j.clon.2007.07.006","article-title":"High dose rate endorectal brachytherapy as a neoadjuvant treatment for patients with resectable rectal cancer","volume":"19","author":"Vuong","year":"2007","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0038","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.clon.2020.06.008","article-title":"Neoadjuvant radiotherapy dose escalation in locally advanced rectal cancer: a systematic review and meta-analysis of modern treatment approaches and outcomes","volume":"33","author":"Hearn","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"17_suppl","key":"10.1016\/j.dld.2024.12.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2023.41.17_suppl.LBA3504","article-title":"Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial","volume":"41","author":"Conroy","year":"2023","journal-title":"JCO"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0040","doi-asserted-by":"crossref","first-page":"29\u201142","DOI":"10.1016\/S1470-2045(20)30555-6","article-title":"Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.dld.2024.12.004_bib0041","doi-asserted-by":"crossref","first-page":"e766\u201172","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial","volume":"278","author":"Dijkstra","year":"2023","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.dld.2024.12.004_bib0042","doi-asserted-by":"crossref","first-page":"322\u201134","DOI":"10.1056\/NEJMoa2303269","article-title":"Preoperative treatment of locally advanced rectal cancer","volume":"389","author":"Schrag","year":"2023","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.dld.2024.12.004_bib0043","doi-asserted-by":"crossref","first-page":"1927\u201134","DOI":"10.1007\/DCR.0b013e3181ba14ed","article-title":"Increasing the rates of complete response to neoadjuvant chemoradiotherapy for distal rectal cancer: results of a prospective study using additional chemotherapy during the resting period","volume":"52","author":"Habr-Gama","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0044","doi-asserted-by":"crossref","first-page":"41\u20119","DOI":"10.1097\/DCR.0000000000002494","article-title":"The risk of distant metastases in patients with clinical complete response managed by watch and wait after neoadjuvant therapy for rectal cancer: the influence of local regrowth in the international watch and wait database","volume":"66","author":"Fernandez","year":"2023","journal-title":"Dis Colon Rectum"},{"issue":"5","key":"10.1016\/j.dld.2024.12.004_bib0045","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1200\/JCO.23.01208","article-title":"Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized phase II OPRA trial","volume":"42","author":"Verheij","year":"2024","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.dld.2024.12.004_bib0046","doi-asserted-by":"crossref","first-page":"356\u201167","DOI":"10.1016\/S2468-1253(22)00392-2","article-title":"Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial","volume":"8","author":"Gerard","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0047","doi-asserted-by":"crossref","first-page":"184\u201190","DOI":"10.1016\/S1470-2045(13)70599-0","article-title":"Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study","volume":"15","author":"Bosset","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.dld.2024.12.004_bib0048","article-title":"Postoperative adjuvant chemotherapy in rectal cancer operated for cure","volume":"2012","author":"Petersen","year":"2012","journal-title":"Cochr Database Syst Rev"},{"issue":"9604","key":"10.1016\/j.dld.2024.12.004_bib0049","first-page":"2020\u20119","article-title":"Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study","volume":"370","author":"R","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.dld.2024.12.004_bib0050","doi-asserted-by":"crossref","first-page":"696\u2011701","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.dld.2024.12.004_bib0051","doi-asserted-by":"crossref","first-page":"200\u20117","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol"},{"issue":"8","key":"10.1016\/j.dld.2024.12.004_bib0052","doi-asserted-by":"crossref","first-page":"979\u201189","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del","year":"2015","journal-title":"Lancet Oncol"},{"issue":"33","key":"10.1016\/j.dld.2024.12.004_bib0053","doi-asserted-by":"crossref","first-page":"3111\u201123","DOI":"10.1200\/JCO.19.00016","article-title":"Oxaliplatin-based adjuvant chemotherapy for rectal cancer after preoperative chemoradiotherapy (ADORE): long-term results of a randomized controlled trial","volume":"37","author":"Hong","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0054","doi-asserted-by":"crossref","first-page":"17\u201129","DOI":"10.1200\/JCO.20.01740","article-title":"Pre- and postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD","volume":"39","author":"Schmoll","year":"2021","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.dld.2024.12.004_bib0055","doi-asserted-by":"crossref","first-page":"3353\u201160","DOI":"10.1200\/JCO.2012.42.5645","volume":"30","author":"Tournigand","year":"2012","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.dld.2024.12.004_bib0056","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/annonc\/mdu147","article-title":"Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus control","volume":"25","author":"Glynne-Jones","year":"2014","journal-title":"Ann Oncol"},{"issue":"25","key":"10.1016\/j.dld.2024.12.004_bib0057","doi-asserted-by":"crossref","first-page":"2363\u201176","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.dld.2024.12.004_bib0058","doi-asserted-by":"crossref","first-page":"176\u201184","DOI":"10.1016\/j.ejca.2022.07.016","article-title":"Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR\/MSI-H rectal cancer: a multicentre cohort study","volume":"174","author":"Wang","year":"2022","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.dld.2024.12.004_bib0059","doi-asserted-by":"crossref","first-page":"38\u201148","DOI":"10.1016\/S2468-1253(21)00348-4","article-title":"Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial","volume":"7","author":"Hu","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"23","key":"10.1016\/j.dld.2024.12.004_bib0060","doi-asserted-by":"crossref","first-page":"2207\u201118","DOI":"10.1056\/NEJMoa2017699","article-title":"Pembrolizumab in microsatellite-instability-high advanced colorectal cancer","volume":"383","author":"Andr\u00e9","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.dld.2024.12.004_bib0061","doi-asserted-by":"crossref","first-page":"659\u201170","DOI":"10.1016\/S1470-2045(22)00197-8","article-title":"Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study","volume":"23","author":"Diaz","year":"2022","journal-title":"Lancet Oncol"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824011174?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824011174?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T02:07:27Z","timestamp":1740622047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824011174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1590865824011174"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.12.004","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rectal cancer - French intergroup clinical practice guidelines for diagnosis, treatment, and follow-up (TNCD, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFP, RENAPE, SNFCP, AFEF, SFR, and GRECCAR)","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}